Please enable JavaScript to continue using this application.

Compare $GLSI vs $TLSI | Chartloom

Compare

$GLSI vs $TLSI

Greenwich Lifesciences Inc · TriSalus Life Sciences Inc

GLSI

Greenwich Lifesciences Inc

TLSI

TriSalus Life Sciences Inc

Compare $GLSI vs $TLSI

Comparing Greenwich Lifesciences Inc and TriSalus Life Sciences Inc

GLSIGreenwich Lifesciences Inc

TLSITriSalus Life Sciences Inc

GLSIGreenwich Lifesciences Inc

Market cap

$243M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-15.1%

52W performance

44.4%

FCF yield

-5.1%

TLSITriSalus Life Sciences Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.61x

Rev growth (TTM)

25.2%

YTD performance

-33.4%

52W performance

-16.3%

FCF yield

-9.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GLSI

TLSI

Detailed metrics comparison

GLSI

Greenwich Lifesciences Inc

TLSI

TriSalus Life Sciences Inc

Market Cap

GLSI$243M

TLSI$249M

Enterprise Value

GLSI$234M

TLSI$236M

Price

GLSI$16.53

TLSI$4.06

P/E Ratio

GLSIN/A

TLSIN/A

P/S Ratio

GLSI0.00x

TLSI5.53x

EV/Sales

GLSI0.00x

TLSI5.24x

EV/EBITDA

GLSI0.00x

TLSI0.00x

P/B Ratio

GLSI79.96x

TLSI40.61x

P/FCF Ratio

GLSIN/A

TLSIN/A

EV/FCF

GLSI-18.72x

TLSI-10.14x

PEG Ratio

GLSIN/A

TLSIN/A

Forward P/E (NTM)

GLSIN/A

TLSIN/A

Forward P/S (NTM)

GLSIN/A

TLSI3.61x

Revenue (TTM)

GLSI$0

TLSI$45M

Revenue Growth (YoY)

GLSIN/A

TLSI25.2%

Forward Rev Growth

GLSI0.0%

TLSI40.1%

Gross Margin (TTM)

GLSI0.0%

TLSI85.8%

Operating Margin (TTM)

GLSI0.0%

TLSI0.0%

EBITDA Margin (TTM)

GLSI0.0%

TLSI-66.4%

Net Margin (TTM)

GLSI0.0%

TLSI-130.2%

FCF Margin (TTM)

GLSIN/A

TLSI-51.6%

Net Income (TTM)

GLSI$-22M

TLSI$-59M

FCF (TTM)

GLSI$-12M

TLSI$-23M

EPS (TTM)

GLSI-$1.48

TLSI-$1.01

ROE (TTM)

GLSI-79376.0%

TLSI-7902.0%

ROA (TTM)

GLSI-29531.0%

TLSI-5499.0%

ROIC (TTM)

GLSI-79376.0%

TLSI-1789.0%

Cash

GLSI$9M

TLSI$46M

Debt

GLSI$0

TLSI$33M

Net Cash/Debt

GLSI$9M

TLSI$13M

Current Ratio (TTM)

GLSI1.54x

TLSI5.35x

Quick Ratio (TTM)

GLSI1.54x

TLSI4.72x

Debt/Equity (TTM)

GLSI0.00x

TLSI5.05x

Debt/Assets (TTM)

GLSI0.0%

TLSI0.0%

Interest Coverage (TTM)

GLSIN/A

TLSIN/A

Net Debt/EBITDA (TTM)

GLSI0.00x

TLSI0.00x

Beta

GLSI1.54

TLSI0.46

52W Performance

GLSI44.4%

TLSI-16.3%

YTD Performance

GLSI-15.1%

TLSI-33.4%

% from 52W High

GLSI-51.5%

TLSI-48.9%

% from 52W Low

GLSI112.5%

TLSI84.5%

Asset Turnover (TTM)

GLSI0.00x

TLSI0.88x

FCF Yield (TTM)

GLSI-5.1%

TLSI-9.3%

Earnings Yield (TTM)

GLSI-8.9%

TLSI-23.5%

Dividend Yield (TTM)

GLSIN/A

TLSIN/A

Rule of 40

GLSI0.0

TLSI-26.4

EV/GP/RG

GLSIN/A

TLSI0.11

Ticker research

View GLSI research View TLSI research

Metric	GLSI Greenwich Lifesciences Inc	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$243M	$249M
Enterprise Value	$234M	$236M
Price	$16.53	$4.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.53x
EV/Sales	0.00x	5.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	79.96x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.72x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.61x
Revenue & Growth
Revenue (TTM)	$0	$45M
Revenue Growth (YoY)	N/A	25.2%
Forward Rev Growth	0.0%	40.1%
Profitability
Gross Margin (TTM)	0.0%	85.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-66.4%
Net Margin (TTM)	0.0%	-130.2%
FCF Margin (TTM)	N/A	-51.6%
Net Income (TTM)	$-22M	$-59M
FCF (TTM)	$-12M	$-23M
EPS (TTM)	-$1.48	-$1.01
ROE (TTM)	-79376.0%	-7902.0%
ROA (TTM)	-29531.0%	-5499.0%
ROIC (TTM)	-79376.0%	-1789.0%
Financial Health
Cash	$9M	$46M
Debt	$0	$33M
Net Cash/Debt	$9M	$13M
Current Ratio (TTM)	1.54x	5.35x
Quick Ratio (TTM)	1.54x	4.72x
Debt/Equity (TTM)	0.00x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	0.46
52W Performance	44.4%	-16.3%
YTD Performance	-15.1%	-33.4%
% from 52W High	-51.5%	-48.9%
% from 52W Low	112.5%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.88x
FCF Yield (TTM)	-5.1%	-9.3%
Earnings Yield (TTM)	-8.9%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-26.4
EV/GP/RG	N/A	0.11
Ticker research	View GLSI research	View TLSI research

Valuation

P/S Ratio

GLSI

0.00x

TLSI

5.53x

EV/FCF

GLSI

-18.72x

TLSI

-10.14x

Growth & revenue

Revenue Growth TTM

TLSI

25.2%

Forward Revenue Growth

TLSI

40.1%

GLSI

0.0%

Profitability & performance

Gross Margin

TLSI

85.8%

GLSI

0.0%

ROE

TLSI

-7902.0%

GLSI

-79376.0%

FCF Yield %

GLSI

-5.1%

TLSI

-9.3%

52-Week Performance

GLSI

44.4%

TLSI

-16.3%

Detailed metrics comparison

GLSI

Greenwich Lifesciences Inc

TLSI

TriSalus Life Sciences Inc

Market Cap

GLSI$243M

TLSI$249M

Enterprise Value

GLSI$234M

TLSI$236M

Price

GLSI$16.53

TLSI$4.06

P/E Ratio

GLSIN/A

TLSIN/A

P/S Ratio

GLSI0.00x

TLSI5.53x

EV/Sales

GLSI0.00x

TLSI5.24x

EV/EBITDA

GLSI0.00x

TLSI0.00x

P/B Ratio

GLSI79.96x

TLSI40.61x

P/FCF Ratio

GLSIN/A

TLSIN/A

EV/FCF

GLSI-18.72x

TLSI-10.14x

PEG Ratio

GLSIN/A

TLSIN/A

Forward P/E (NTM)

GLSIN/A

TLSIN/A

Forward P/S (NTM)

GLSIN/A

TLSI3.61x

Revenue (TTM)

GLSI$0

TLSI$45M

Revenue Growth (YoY)

GLSIN/A

TLSI25.2%

Forward Rev Growth

GLSI0.0%

TLSI40.1%

Gross Margin (TTM)

GLSI0.0%

TLSI85.8%

Operating Margin (TTM)

GLSI0.0%

TLSI0.0%

EBITDA Margin (TTM)

GLSI0.0%

TLSI-66.4%

Net Margin (TTM)

GLSI0.0%

TLSI-130.2%

FCF Margin (TTM)

GLSIN/A

TLSI-51.6%

Net Income (TTM)

GLSI$-22M

TLSI$-59M

FCF (TTM)

GLSI$-12M

TLSI$-23M

EPS (TTM)

GLSI-$1.48

TLSI-$1.01

ROE (TTM)

GLSI-79376.0%

TLSI-7902.0%

ROA (TTM)

GLSI-29531.0%

TLSI-5499.0%

ROIC (TTM)

GLSI-79376.0%

TLSI-1789.0%

Cash

GLSI$9M

TLSI$46M

Debt

GLSI$0

TLSI$33M

Net Cash/Debt

GLSI$9M

TLSI$13M

Current Ratio (TTM)

GLSI1.54x

TLSI5.35x

Quick Ratio (TTM)

GLSI1.54x

TLSI4.72x

Debt/Equity (TTM)

GLSI0.00x

TLSI5.05x

Debt/Assets (TTM)

GLSI0.0%

TLSI0.0%

Interest Coverage (TTM)

GLSIN/A

TLSIN/A

Net Debt/EBITDA (TTM)

GLSI0.00x

TLSI0.00x

Beta

GLSI1.54

TLSI0.46

52W Performance

GLSI44.4%

TLSI-16.3%

YTD Performance

GLSI-15.1%

TLSI-33.4%

% from 52W High

GLSI-51.5%

TLSI-48.9%

% from 52W Low

GLSI112.5%

TLSI84.5%

Asset Turnover (TTM)

GLSI0.00x

TLSI0.88x

FCF Yield (TTM)

GLSI-5.1%

TLSI-9.3%

Earnings Yield (TTM)

GLSI-8.9%

TLSI-23.5%

Dividend Yield (TTM)

GLSIN/A

TLSIN/A

Rule of 40

GLSI0.0

TLSI-26.4

EV/GP/RG

GLSIN/A

TLSI0.11

Ticker research

View GLSI research View TLSI research

Metric	GLSI Greenwich Lifesciences Inc	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$243M	$249M
Enterprise Value	$234M	$236M
Price	$16.53	$4.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.53x
EV/Sales	0.00x	5.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	79.96x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.72x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.61x
Revenue & Growth
Revenue (TTM)	$0	$45M
Revenue Growth (YoY)	N/A	25.2%
Forward Rev Growth	0.0%	40.1%
Profitability
Gross Margin (TTM)	0.0%	85.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-66.4%
Net Margin (TTM)	0.0%	-130.2%
FCF Margin (TTM)	N/A	-51.6%
Net Income (TTM)	$-22M	$-59M
FCF (TTM)	$-12M	$-23M
EPS (TTM)	-$1.48	-$1.01
ROE (TTM)	-79376.0%	-7902.0%
ROA (TTM)	-29531.0%	-5499.0%
ROIC (TTM)	-79376.0%	-1789.0%
Financial Health
Cash	$9M	$46M
Debt	$0	$33M
Net Cash/Debt	$9M	$13M
Current Ratio (TTM)	1.54x	5.35x
Quick Ratio (TTM)	1.54x	4.72x
Debt/Equity (TTM)	0.00x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	0.46
52W Performance	44.4%	-16.3%
YTD Performance	-15.1%	-33.4%
% from 52W High	-51.5%	-48.9%
% from 52W Low	112.5%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.88x
FCF Yield (TTM)	-5.1%	-9.3%
Earnings Yield (TTM)	-8.9%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-26.4
EV/GP/RG	N/A	0.11
Ticker research	View GLSI research	View TLSI research